CoChat

Combination Antifungal Therapy for Cryptococcal Meningitis

· 2013 · New England Journal of Medicine
Cited by 78

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Combination Antifungal Therapy for Cryptococcal MeningitisTo the Editor: In the trial of combination therapy for cryptococcal meningitis in patients with human immunodeficiency virus infection, Day et al. (April 4 issue) 1 found a survival benefit associated with 2 weeks of therapy with amphotericin B and flucytosine as compared with amphotericin B monotherapy.The results of this trial reinforce the treatment combination as the standard per current guidelines. 2,3 In locations where amphotericin B therapy is not feasible, flucytosine is recommended in combination with fluconazole. 2-4However, the availability of flucytosine worldwide remains grossly inadequate.Flucytosine is currently unregistered and unavailable in most of Asia and Africa, where the disease burden is greatest. 5Even though flucytosine is a simple, orally administered, off-patent drug, only two manufacturers have been approved by the Food and Drug Administration: the originator company, Meda Pharmaceuticals, and the generic manufacturer, Sigmapharm Laboratories.The lack of data about disease burden, concerns regarding toxicity, and high drug costs due to a lack of competition have contributed to a market failure for flucytosine. 5Given the findings of Day et al., sustained efforts from governmental and international stakeholders are now required in order to urgently disseminate and implement World Health Organization (WHO) treatment guidelines, facilitate the registration of flucytosine, motivate generic-drug production, stimulate development of sustained-release formulations of flucytosine, and widen access to this drug.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmc1305981

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 78

Metadata

Venue
New England Journal of Medicine
Published
2013-06-27
Volume
368
Issue
26
Pages
2522-2523
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W3146780943
Cited by
78
References
5
FWCI
6.49
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combination Antifungal Therapy for Cryptococcal Meningitis. https://app.cochat.ai/papers/10.1056/nejmc1305981
The paper
Combination Antifungal Therapy for Cryptococcal Meningitis. (2013). New England Journal of Medicine. https://doi.org/10.1056/nejmc1305981

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.